scholarly journals GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment

10.5772/48444 ◽  
2013 ◽  
Author(s):  
Xiaoyun Zhu ◽  
Wenglong Huang ◽  
Hai Qi
Keyword(s):  
Type 2 Diabetes ◽  
Diabetes Treatment ◽  
Type 2 Diabetes Treatment ◽  
Novel Strategy

scholarly journals Carbohydrate digestive enzymes are inhibited by Poincianella pluviosa stem bark extract: relevance on type 2 diabetes treatment

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Camila Gabriel Kato-Schwartz ◽  
Anacharis Babeto de Sá-Nakanishi ◽  
Ana Carolina Guidi ◽  
Geferson de Almeida Gonçalves ◽  
Fernanda Giacomini Bueno ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Digestive Enzymes ◽  
Stem Bark ◽  
Bark Extract ◽  
Diabetes Treatment ◽  
Type 2 Diabetes Treatment ◽  
Stem Bark Extract

scholarly journals Type 2 Diabetes Treatment and Drug Development Study

2018 ◽  
Vol 8 (1) ◽  
pp. 22-33 ◽  
Author(s):  
Da-Yong Lu ◽  
Jin-Yu Che ◽  
Nagendra Sastry Yarla ◽  
Hong-Ying Wu ◽  
Ting-Ren Lu ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Drug Targets ◽  
Medical Knowledge ◽  
Modern Medicine ◽  
Diabetes Treatment ◽  
Candidate Drug ◽  
The Future ◽  
Type 2 Diabetes Treatment ◽  
And Personalized Medicine

The causality and etio-pathologic risks for patients with Type 2 Diabetes (T2DM) are important areas in modern medicine. Disease complications are largely unpredictable in patients with T2DM. In the future, we welcome therapeutics of both cutting-edge and traditional for anti-diabetic treatments and management with higher efficiency and less cost. Expanding medical knowledge, behavior/life-style notification in healthcare, modern genetic/bioinformatics diagnostic promotion, clinical developments (Traditional Chinese Medicine and personalized medicine) and new drug developments - including candidate drug targets should be implemented in the future. These efforts might be useful avenues for updating anti-diabetic therapeutics globally. This article aims at introducing this information for T2DM treatment boosts.

Discovery of potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor SGL5213 for type 2 diabetes treatment

2019 ◽  
Vol 27 (2) ◽  
pp. 394-409 ◽  
Author(s):  
Shoichi Kuroda ◽  
Yohei Kobashi ◽  
Takahiro Oi ◽  
Kenichi Kawabe ◽  
Fumiyasu Shiozawa ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Diabetes Treatment ◽  
Sodium Dependent ◽  
Type 2 Diabetes Treatment

scholarly journals Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment

PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0149409 ◽  
Author(s):  
Paola C. Rosas ◽  
Ganachari M. Nagaraja ◽  
Punit Kaur ◽  
Alexander Panossian ◽  
Georg Wickman ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Islet Amyloid Polypeptide ◽  
Human Islet ◽  
Diabetes Treatment ◽  
Islet Amyloid ◽  
New Approach ◽  
Human Islet Amyloid Polypeptide ◽  
Type 2 Diabetes Treatment

The role of education in type 2 diabetes treatment

2019 ◽  
Vol 151 ◽  
pp. 237-246 ◽  
Author(s):  
Natalia Świątoniowska ◽  
Kathie Sarzyńska ◽  
Anna Szymańska-Chabowska ◽  
Beata Jankowska-Polańska
Keyword(s):  
Type 2 Diabetes ◽  
Diabetes Treatment ◽  
Type 2 Diabetes Treatment

scholarly journals Physicians’ Perceptions of the Type 2 Diabetes Multi-disciplinary Treatment Team

2011 ◽  
Vol 37 (6) ◽  
pp. 794-800 ◽  
Author(s):  
Marilyn D. Ritholz ◽  
Elizabeth A. Beverly ◽  
Martin J. Abrahamson ◽  
Kelly M. Brooks ◽  
Brittney A. Hultgren ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Multidisciplinary Team ◽  
Team Approach ◽  
Diabetes Treatment ◽  
Treatment Team ◽  
Team Members ◽  
Assessment And Treatment ◽  
Type 2 Diabetes Treatment ◽  
Consistent Information

Purpose The purpose of this study was to explore physicians’ perceptions of the multidisciplinary type 2 diabetes treatment team. Methods Nineteen physicians (74% endocrinologists; 26% primary care) participated in semistructured interviews. Audiorecorded data were transcribed, coded, and analyzed using thematic analysis and NVivo 8 software. Results Physicians considered the multidisciplinary team, including a physician and diabetes educator, as very important to diabetes treatment. Participants described how diabetes, with its many comorbidities and challenging lifestyle recommendations, is difficult for any single physician to treat. They further described how the team’s diverse staff offers complementary skills and more contact time for assessment and treatment of patients, developing treatment relationships, and supporting patients in learning diabetes self-care. Physicians stressed the necessity of regular and ongoing communication among team members to ensure patients receive consistent information, and some reported that institutional factors interfere with intra-team communication. They also expressed concerns about the team approach in relation to individualized treatment and patients’ reluctance to see multiple providers. Conclusions This study highlights physicians’ positive perceptions of and concerns about the type 2 diabetes multidisciplinary team. Further study of diabetes educators’ and patients’ perceptions of the team approach is needed.

scholarly journals Safety of Type 2 Diabetes Treatment With Repaglinide Compared With Glibenclamide in Elderly People: A randomized, open-label, two-period, cross-over trial

Diabetes Care ◽  
2006 ◽  
Vol 29 (8) ◽  
pp. 1918-1920 ◽  
Author(s):  
G. Papa ◽  
V. Fedele ◽  
M. R. Rizzo ◽  
M. Fioravanti ◽  
C. Leotta ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Elderly People ◽  
Diabetes Treatment ◽  
Open Label ◽  
Type 2 Diabetes Treatment
Sign in / Sign up

Export Citation Format

Share Document